Understanding the Impact of Immunotherapy on Head and Neck Cancer
Understanding the Impact of Immunotherapy on Head and Neck Cancer
Course Director, Robert L. Ferris, MD, PhD, discusses immunotherapy in head and neck cancer in this CME/CE/CPE activity titled “Understanding the Impact of Immunotherapy on Head and Neck Cancer: A Look at the Science, Practice, and Future of Multimodal Treatment.” For the full presentation, downloadable Practice Aids and slides, complete CME/CE/CPE information, and to apply for credit, please visit us at http://www.peerview.com/RBS865. CME/CE/CPE credit will be available until November 1st, 2018.
Immunotherapy News from China
- UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
- …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
- UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
- …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
- …Dosed in First-in-Human Clinical Study of Immunotherapy …
- JITC tumor and cancer immunotherapy papers collection
- Welcome to the submission|Journal for ImmunoTherapy of Cancer
- Immunotherapy shows promise for advanced lymphoma: study
- …from the Monotherapy Arm at the Phacilitate Immunotherapy …
- Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
Leave a Reply
You must be logged in to post a comment.